Company · CIK 0001703647 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Korro Bio, Inc. · KRRO
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2026 SForm 4 → | Sep 15, 4:15 pm EDT | Jean Francois FormelaDirector | 48,690 | $14.09 | $686,177 | 132,650 | −26.9% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 4:05 pm EDT | Oliver DolanSenior Vice President, Finance | 5 | $13.72 | $69 | 16,241 | −0.03% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 10, 4:05 pm EDT | Oliver DolanSenior Vice President, Finance | 7,353 | $13.51 | $99,368 | 16,246 | −31.2% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.